Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
John J. Horan
Through heavy investments in research and development, Horan led Merck to become the leading U.S.-based manufacturer of prescription drugs in the world. Under Horan’s leadership, Merck doubled their spending on research – spending more... View Details
Keywords: Healthcare
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients, expectations were high, with some... View Details
Keywords: Sean Silverthorne
- Web
1. Standards of Conduct | MBA
2.3 Community Standards of Conduct 2.3.1 Drug & Alcohol Policy 2.3.2 Hazing 2.3.3 Non-Discrimination & Anti-Bullying 2.3.4 Sexual & Gender Based Harassment & Other Sexual Misconduct 2.3.5 Research Misconduct 2.3.6 Dangerous Weapons &... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
Robert F. Dee
During his CEO tenure, Dee achieved an 800% increase in revenues (over $3 billion) – moving SmithKline into the upper echelons of major pharmaceutical organizations. He introduced the anti-ulcer medication, Tagamet, which became the largest selling prescription View Details
Keywords: Healthcare
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug development strategy that... View Details
William B. Bell
coating resins, as well as melamine resins, which were used in making work surfaces impervious to scratches and stains. During the 1940s and 50s, Bell also expanded American Cyanamid's activities in drug research and production. View Details
Keywords: Chemicals & Industrial
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
Keywords: Healthcare
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details
Randall L. Tobias
The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar for cancer), solidified and... View Details
Keywords: Healthcare
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill costs 5 cents to manufacture,... View Details
Keywords: by Max H. Bazerman
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
South Africa over its attempt to reduce the cost of HIV drugs through parallel importation (buying pharmaceuticals in countries with lower prices and then importing them) and compulsory licensing (requiring patent holders to allow others... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details